Analysis

Major investment firms are building significant positions in Danaher Corporation, signaling confidence in the life sciences and diagnostics specialist despite...

As March 2026 unfolds, Innoviva continues to solidify its standing within the specialized healthcare market. Investor attention is pivoting toward...

Sangamo Therapeutics is advancing decisively with its investigational gene therapy, ST-920, for Fabry disease. The company has submitted critical data...

In an unprecedented move citing national security, the U.S. government has mandated the restart of a long-dormant California offshore oil...

Anixa Biosciences continues to advance its oncology pipeline, supported by encouraging clinical data and a shareholder-endorsed management team. Recent developments...

A unique confluence of high precious metal prices and stringent cost control is currently creating a highly favorable environment for...

Microvision is staking its future on a single, high-stakes strategy. The laser sensor specialist is attempting to force a breakthrough...

The market is sending mixed signals about Freeport-McMoRan. Despite the mining behemoth posting quarterly profits that significantly outpaced analyst forecasts,...

As the market reassesses winners in the artificial intelligence arena, chip designer Marvell Technology is drawing significant attention from heavyweight...

Once hailed as a pioneer of next-generation nuclear technology, NuScale Power is navigating a difficult start to 2026. The specialist...